vialaudit
CJC-1295 WITH DAC·US LEGAL STATUS·LAST CHECKED 1 NOV 2026

Is CJC-1295 with DAC legal?

Not as a drug. CJC-1295 with DAC has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. Pharmacies cannot compound it.

RESEARCH-LABELLED SALE
Unapproved drug
PHARMACY COMPOUNDING
No · PCAC voted against
PRESCRIPTION
No approved product
WADA 2026
Prohibited (S2.2.4)

DESCRIBES THE LAW · NOT LEGAL ADVICE · NO DOSING INFORMATION

Federal, compounding and sport status

CHECKED 1 NOV 2026

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA interim category: Nominated but withdrawn (off Category 2, not eligible)
503A Bulks List: voted no
Not eligible. The PCAC voted 13-0 against every DAC form on 4 Dec 2024. FDA now lists CJC-1295 under 'nominated but withdrawn' (no longer Category 2), which does not permit compounding.
PCAC review history
  • Dec 4, 2024 · voted against · 13 no, 0 yes on each DAC form · SOURCE ↗
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: PCAC vote and Category 2 posture mean any human-use marketing is an FDCA §505/§301 violation.
Personal possession: Not federally criminalized (federal). State scheduling in Florida creates criminal exposure.

Sport-body status

WADA 2026
prohibited · class S2.2.4 · in and out of competition
CJC-1295 is named under S2.2.4 (GHRH analogues).
USADA
NCAA

What we couldn’t verify

CJC-1295 with DAC US legal status, checked 12 Oct 2026: research sale Unapproved drug, compounding No · PCAC voted against, prescription No approved product, WADA 2026 Prohibited (S2.2.4), 0 FDA warning letters
CJC-1295 with DAC federal, compounding and sport status, checked 12 Oct 2026. Describes the law, not legal advice.

State rules

NONE FOUND

We found no state statute, board rule or enforcement action that names CJC-1295 with DAC. The federal position above applies in all 50 states and DC.

What changed at the last check

3 CHANGES
DateFieldWasNowWhy
12 Oct 2026FDA Category 2 (safety risk)on listnot on listFDA's Category 2 page lists it under 'nominated but withdrawn', not in Category 2. source ↗
12 Oct 2026WADA 2026prohibited (S2.2)prohibited (S2.2.4)CJC-1295 is named under S2.2.4 (GHRH analogues). source ↗
12 Oct 2026FL state noteFlorida § 893.03(3) (HB 1041, eff. 2013 10 01) explicitly schedules CJC 1295 as Schedule III. Possession/distribution ofremovedRemoved. Florida Statutes §893.03 (2025) names no peptide, GHRH analogue or GH secretagogue in Schedule III; the earlier entry was wrong. source ↗

Questions

3 ANSWERS
Is CJC-1295 with DAC legal in the US?

Not as a drug. CJC-1295 with DAC has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. Pharmacies cannot compound it.

Can a pharmacy compound CJC-1295 with DAC?

Not eligible. The PCAC voted 13-0 against every DAC form on 4 Dec 2024. FDA now lists CJC-1295 under 'nominated but withdrawn' (no longer Category 2), which does not permit compounding.

Is CJC-1295 with DAC banned in sport?

Yes. It is prohibited at all times under WADA 2026 class S2.2.4. CJC-1295 is named under S2.2.4 (GHRH analogues).

Sources

6 DOCUMENTS
  1. FDA approval record
  2. DEA controlled-substance schedules
  3. FDA 503A compounding position
  4. PCAC review, 4 Dec 2024
  5. WADA 2026 Prohibited List
  6. Source for: FL state note
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH